David Walt and George Church receive grant from Chan Zuckerberg Initiative to enable better diagnosis and monitoring of Parkinson’s disease
December 5, 2018 Project combines highly sensitive biomarker discovery with human stem cell technology to develop a much needed blood diagnostic assay for Parkinson’s disease By Benjamin Boettner
Thrive Global | November 12, 2018
This Sunday was Veterans Day, a time to honor those who have selflessly served our country. While our veterans are front and center on this day, they have been missing from a critical conversation over the past couple of years. By Kevin Hrusovsky
Multiple Sclerosis News Today | October 12, 2018
By Jose Marques Lopez, PhD
SPORTTECHIE | September 07, 2018
By Joe Lemire
SPORTTECHIE | September 06, 2018
By Joe Lemire
Washington Report | September 04, 2018
By: Kevin Hrusovsky
ALZFORUM.ORG | August 24, 2018
A lot can happen in a year.
Specialty Pharmacy Times | August 17, 2018
A new technology allows researchers to use brain biomarker neurofilament light chain (NfL) to uncover insights into the development and progression of neurological diseases, such as multiple sclerosis (MS).
Genetic Engineering & Biotechnology News | January 15, 2018
New technology has shown promise for detecting CTE and the approximately 150 protein biomarkers linked to conditions in neurology, oncology, cardiology, inflammation, and infectious disease. Called Simoa™, it is a single-molecule array on a fully automated digital immunoassay platform that detects…
Alzforum | November 17, 2017
Serum NfL levels rise before symptoms appear in familial AD. NfL correlates with cognitive decline and brain atrophy. In MS patients, NfL levels drop with treatment.